The Semaglutide Compounding Dispute intensifies as Novo Nordisk takes iDexis to court over illegal manufacturing of weight-loss injections. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
SA pharma localisation faces hurdles as Trade Minister warns against foreign investor conditions that undermine domestic procurement. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
